Meet with Myval THV series with real world case-based learning

Sponsored by Meril Life Sciences
TAVI
Symposium
Meril Life
The Forum

Anchorperson: Francesco Maisano

Spokesperson: Thomas Cuisset

Discussants: Ignacio J Amat-Santos, Giovanni Esposito, Phillip Freeman, Andreas Rück

Watch this session if you want

  • To know about the novel Myval transcatheter heart valve (THV) series and its role in lifetime management of TAVI patients
  • To appreciate the utility of intermediate and extra-large device sizing and the relationship between foreshortening and accurate deployment of THV
  • To hear about pivotal trials of Myval THV series and their relevance in clinical practice
Welcome and session objectives

 

Case presentation - Lifetime considerations for TAVI patient

 

Matching prosthesis to patient - Clinical and practical relevance of intermediate valve sizing

Phillip Freeman

XL size relevance not as trivial as it seems - Sizing considerations

 

Clinical updates from the pivotal Myval THV Series - Unique characteristics driving real-world clinical outcomes

Ignacio J Amat-Santos

The Pro effect and the importance of predictable valve deployment in challenging anatomical situations

Andreas Rück

Simulation-based case conclusion

 

Session evaluation and key learnings

 

Suggested videos